Transaction Breakdown
Companies & Roles
Discretionary Trading P&L
Holdings
Transaction History
About Mutz Christopher
Mutz Christopher (SEC CIK 0001846487) files insider reports with the SEC as HEAD OF RARE DISEASE of ANI PHARMACEUTICALS INC (ANIP).
Signal8 holds 12 ownership filings by Mutz Christopher, all Form 4s, filed between Nov 18, 2024 and Mar 13, 2026. Those filings report 20 transactions, the latest on Mar 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mutz Christopher's filings is in BAUDETTE, MN.
Other insiders filing for ANI PHARMACEUTICALS INC (ANIP)
- CAREY STEPHEN P., SVP & CFO
- Lalwani Nikhil, PRESIDENT & CEO
- Cook Meredith, SR. VP, GENERAL COUNSEL & SEC.
- Thoma Jeanne, Director
- Gosebruch Henry O, Director
- Gutwerg Ori, SVP, GENERICS